CUA: Testosterone Suppression (2018): Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

11 November 2022

  • curprev 13:3913:39, 11 November 2022‎ Urology4all talk contribs‎ 3,961 bytes +3,961‎ Created page with " '''See Original Guideline''' ===== Benefit of low testosterone during androgen-deprivation therapy (ADT) ===== * See Hormonal Therapy Chapter Notes * ADT is the standard first-line treatment for men with recurrent or metastatic prostate cancer. * Studies have consistently demonstrated the clinical benefit and importance of greater testosterone suppression during ADT. ** The largest trial (PR-7) enrolled 626 patients with localized or locally advanced prostate cancer..." Tag: Visual edit
Retrieved from "https://urologyschool.com/wikiuro/index.php/CUA:_Testosterone_Suppression_(2018)"